Cargando…

Emergency Combination of Four Drugs for Bloodstream Infection Caused by Carbapenem-Resistant Enterobacteriaceae in Severe Agranulocytosis Patients with Hematologic Malignancies after Hematopoietic Stem Cell Transplantation

Bloodstream infection (BSI) caused by multidrug-resistant (MDR) bacteria or extensively drug-resistant (XDR) bacteria is a global threat. However, an effective treatment regimen is still controversial and inadequate due to the rapid deterioration caused by the bacteria. In immunocompromised and neut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaofan, Hong, Yaqun, Chen, Xianling, Chen, Ping, Li, Nainong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424386/ https://www.ncbi.nlm.nih.gov/pubmed/32832159 http://dx.doi.org/10.1155/2020/9358426

Ejemplares similares

Successful treatment with HLA-matched peripheral hematopoietic stem cell transplantation for very severe hepatitis-associated aplastic anemia complicated with multidrug-resistant bacterial and fungal infections: A case report
por: Li, Hua, et al.
Publicado: (2022)

High risk of bloodstream infection of carbapenem-resistant enterobacteriaceae carriers in neutropenic children with hematological diseases
por: Liu, Li-Peng, et al.
Publicado: (2023)

Clinical Analysis of Bloodstream Infections During Agranulocytosis After Allogeneic Hematopoietic Stem Cell Transplantation
por: Cao, Weijie, et al.
Publicado: (2021)

Sequential Transplantation of Haploidentical Stem Cell and Unrelated Cord Blood With Using ATG/PTCY Increases Survival of Relapsed/Refractory Hematologic Malignancies
por: Li, Hua, et al.
Publicado: (2021)

Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation
por: Cao, Weijie, et al.
Publicado: (2022)

Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options
por: Zhang, Lining, et al.
Publicado: (2023)

Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae
por: Li, Xiaopeng, et al.
Publicado: (2017)

A Case of Acute Lymphocytic Leukaemia with t(3;13) and Central Nervous System Leukemia after Allogenic Cord Blood Transplantation
por: Li, Xiaofan, et al.
Publicado: (2019)

Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Zhu, Yunying, et al.
Publicado: (2021)

Development of a Risk Prediction Model of Subsequent Bloodstream Infection After Carbapenem-Resistant Enterobacteriaceae Isolated from Perianal Swabs in Hematological Patients
por: Liu, Jia, et al.
Publicado: (2023)

Carbapenem-Resistant Enterobacteriaceae—Implications for Treating Acute Leukemias, a Subgroup of Hematological Malignancies
por: Storhaug, Kristin Ølfarnes, et al.
Publicado: (2021)

Clinical Characteristics and Prognosis of Bloodstream Infection with Carbapenem-Resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancies
por: Yuan, Fangfang, et al.
Publicado: (2023)

Emergence of High-Level Cefiderocol Resistance in Carbapenem-Resistant Klebsiella pneumoniae from Bloodstream Infections in Patients with Hematologic Malignancies in China
por: Lan, Peng, et al.
Publicado: (2022)

A Visualized Mortality Prediction Score Model in Hematological Malignancies Patients with Carbapenem-Resistant Organisms Bloodstream Infection
por: Qian, Chenjing, et al.
Publicado: (2023)

Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2015)

Clinical Characteristics and Associated Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection
por: Ahn, Jin Young, et al.
Publicado: (2023)

434 Prevalence, Risk Factors, and Outcomes of Bacteremia Caused by Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies
por: Satlin, Michael J., et al.
Publicado: (2014)

Bloodstream Infections in Patients with Rectal Colonization by Carbapenem-Resistant Enterobacteriaceae: A Prospective Cohort Study
por: Chu, Wenwen, et al.
Publicado: (2022)

Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
por: Meng, Haiyang, et al.
Publicado: (2022)

Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection Treated Successfully With High-Dose Meropenem in a Preterm Neonate
por: Wu, Yue-E, et al.
Publicado: (2020)

Construction of a Risk Prediction Model for Subsequent Bloodstream Infection in Intestinal Carriers of Carbapenem-Resistant Enterobacteriaceae: A Retrospective Study in Hematology Department and Intensive Care Unit
por: Wang, Yue, et al.
Publicado: (2021)

The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections
por: Lu, Linli, et al.
Publicado: (2022)

Different screening frequencies of carbapenem-resistant Enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better?
por: Yang, Ting-Ting, et al.
Publicado: (2020)

Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
por: Zhang, Piaopiao, et al.
Publicado: (2020)

Risk Factors for Carbapenem-Resistant Enterobacteriaceae Colonization and the Effect on Clinical Outcomes and Prognosis in Allogeneic Hematopoietic Stem Cell Transplanted Patients
por: Wu, Wen-Qi, et al.
Publicado: (2023)

Gut Colonization with Carbapenem-resistant Enterobacteriaceae Adversely Impacts the Outcome in Patients with Hematological Malignancies: Results of A Prospective Surveillance Study
por: Jaiswal, Sarita Rani, et al.
Publicado: (2018)

Efficacy and safety of tandem autologous stem cell transplantation in multiple myeloma: a retrospective single-center analysis
por: Wu, Shunquan, et al.
Publicado: (2023)

Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant Recipients
por: Zhang, Liyang, et al.
Publicado: (2022)

Prevention and management of carbapenem-resistant Enterobacteriaceae in haematopoietic cell transplantation
por: Sahitya, Dangudubiyyam Sri Krishna, et al.
Publicado: (2021)

Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies
por: Fabricius, William A., et al.
Publicado: (2016)

Viral Pneumonia in Patients with Hematopoietic Cell Transplantation and Hematologic Malignancies
por: Green, Margaret L.
Publicado: (2017)

Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae
por: Dong, Le Thanh, et al.
Publicado: (2020)

Resistance Pattern of Carbapenem on Enterobacteriaceae
por: Pokharel, Khilasa, et al.
Publicado: (2018)

Four Cases of Carbapenem-Resistant Enterobacteriaceae Infection from January to March in 2014
por: Kim, So Ri, et al.
Publicado: (2015)

Active Surveillance for Carbapenem-resistant Enterobacteriaceae at a Single Center for Four Years
por: Choi, Inho, et al.
Publicado: (2022)

Agranulocytosis
Publicado: (1945)

Agranulocytosis
Publicado: (1933)

Agranulocytosis
Publicado: (1935)

Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies
por: Marques Jr, José Francisco Comenalli
Publicado: (2011)

Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders
por: Mahmoud, Hossam K., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v5fq3bd5sdu6s006pf554mk9aj